Skip to main content
. 2022 Jun 25;298(8):102198. doi: 10.1016/j.jbc.2022.102198

Figure 5.

Figure 5

Post-translational modifications of DUBs.45,142,143,148,159,160,166,168,201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215 AT3, ataxin3; BAP1, BRCA1-associated protein 1; CC, coiled-coil; CFTR, cystic fibrosis transmembrane conductance regulator; CK2, casein kinase 2, CTD, C-terminal domain; DTT, dithiothreitol; DUB, deubiquitinase; FOXK, forkhead box class K; Glu, glutamylation; GSK3, glycogen synthase kinase 3; HBM, HCF-1 binding motif; MALT1, mucosa-associated lymphoid tissue lymphoma translocation protein 1; MJD, Machado–Joseph deubiquitinases; NFκB, nuclear factor kappa B; NES, nuclear exporting signal; NLS, nuclear localization signal; P, phosphorylation; QQQ, poly-Q region; SUMO, SUMOylation; SIM, SUMO-interacting motif; Ub, ubiquitin; UBA, Ub-associated domain; UCH, Ub-C terminal hydrolase; UIM, Ub-interacting motif; USP, ubiquitin carboxyl-terminal hydrolase; ZF, zing finger.